Review



antibodies against ec sod  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems antibodies against ec sod
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Antibodies Against Ec Sod, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc12442531-87-45-50?v=R%26D+Systems
    Average 94 stars, based on 18 article reviews
    antibodies against ec sod - by Bioz Stars, 2026-08
    94/100 stars

    Images

    1) Product Images from "Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia"

    Article Title: Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia

    Journal: American journal of physiology. Lung cellular and molecular physiology

    doi: 10.1152/ajplung.00399.2024

    Low vascular EC-SOD exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Figure Legend Snippet: Low vascular EC-SOD exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.

    Techniques Used: Expressing, Knock-Out

    Single dose of SOD mimetic before hypoxia attenuates pulmonary hypertension and vascular remodeling. A : chronic hypoxic pulmonary hypertension was assessed by direct right ventricle (RV) puncture and measurement of RV systolic pressure (RVSP). B : RV hypertrophy was assessed by right ventricle/left ventricle + septum weights. Muscularization of small pulmonary vessels after 21 days of hypoxia was evaluated using α-smooth muscle actin (α-SMA) antibody staining (purple) of lung sections from hypoxic mice treated with SOD mimetic or vehicle (PBS) compared with normoxic controls. Costaining was performed with HA-BP to also detect hyaluronan (brown). C : vessel muscularization at 21 days was quantified by counting the number of muscularized small vessels (<50 μm) with positive staining for α-SMA counted per high-power field (HPF). D : representative images taken at ×10 magnification (scale bars represent 200 μm) with muscularized vessels indicated with black arrows. One-way ANOVA, Tukey’s post hoc tests for multiple comparisons, n = 5–9 mice per group. Female mice indicated with closed symbols. All data expressed as means ± SD. HA-BP, hyaluronan-binding protein; Hx, hypoxia; Nx, normoxia; SOD, superoxide dismutase.
    Figure Legend Snippet: Single dose of SOD mimetic before hypoxia attenuates pulmonary hypertension and vascular remodeling. A : chronic hypoxic pulmonary hypertension was assessed by direct right ventricle (RV) puncture and measurement of RV systolic pressure (RVSP). B : RV hypertrophy was assessed by right ventricle/left ventricle + septum weights. Muscularization of small pulmonary vessels after 21 days of hypoxia was evaluated using α-smooth muscle actin (α-SMA) antibody staining (purple) of lung sections from hypoxic mice treated with SOD mimetic or vehicle (PBS) compared with normoxic controls. Costaining was performed with HA-BP to also detect hyaluronan (brown). C : vessel muscularization at 21 days was quantified by counting the number of muscularized small vessels (<50 μm) with positive staining for α-SMA counted per high-power field (HPF). D : representative images taken at ×10 magnification (scale bars represent 200 μm) with muscularized vessels indicated with black arrows. One-way ANOVA, Tukey’s post hoc tests for multiple comparisons, n = 5–9 mice per group. Female mice indicated with closed symbols. All data expressed as means ± SD. HA-BP, hyaluronan-binding protein; Hx, hypoxia; Nx, normoxia; SOD, superoxide dismutase.

    Techniques Used: Staining, Binding Assay

    Perivascular Lyve1 + IMs are increased in EC-SOD SMC KO following 4 days of hypoxia and colocalize with HA. Lung sections were stained with a panel of antibodies to identify macrophage populations around pulmonary vessels in floxed WT controls and EC-SOD SMC KO mice at baseline (left hand side images) and during peak hypoxia-induced IM accumulation (4 D Hx; right hand side images). Immunofluorescence imaging was performed on the Vectra Polaris (Akoya) using inForm software. F480 was used to label all macrophages in white ( A ), CD163 in green ( B ), and Lyve1 in yellow ( C ) were used to label the Lyve1 + IM subset. α-SMA was used to identify smooth muscle (blue) in panels. Representative images showing increased interstitial macrophages in hypoxic WT and hypoxic EC-SOD SMC KO mice are shown from n = 3 mice per group; 40 magnification, scale bars 20 μm. White arrows indicate Lyve1-IMs and yellow arrows indicate Lyve1 + IMs in each section. D : adjacent lung sections were costained for α-SMA (purple) actin; EC-SOD, and HA-BP to detect perivascular hyaluronan (brown). Representative images taken at ×40 magnification (scale bars = 50 μm) from n = 3–5 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice used were male. α-SMA, α-smooth muscle actin; EC-SOD, extracellular superoxide dismutase; HA, hyaluronan; HA-BP, hyaluronan-binding protein; Hx, hypoxia; IMs, interstitial macrophages; KO, knockout; Lyve1, lymphatic vessel endothelial hyaluronan receptor 1; Nx, normoxia; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain; WT, wild type.
    Figure Legend Snippet: Perivascular Lyve1 + IMs are increased in EC-SOD SMC KO following 4 days of hypoxia and colocalize with HA. Lung sections were stained with a panel of antibodies to identify macrophage populations around pulmonary vessels in floxed WT controls and EC-SOD SMC KO mice at baseline (left hand side images) and during peak hypoxia-induced IM accumulation (4 D Hx; right hand side images). Immunofluorescence imaging was performed on the Vectra Polaris (Akoya) using inForm software. F480 was used to label all macrophages in white ( A ), CD163 in green ( B ), and Lyve1 in yellow ( C ) were used to label the Lyve1 + IM subset. α-SMA was used to identify smooth muscle (blue) in panels. Representative images showing increased interstitial macrophages in hypoxic WT and hypoxic EC-SOD SMC KO mice are shown from n = 3 mice per group; 40 magnification, scale bars 20 μm. White arrows indicate Lyve1-IMs and yellow arrows indicate Lyve1 + IMs in each section. D : adjacent lung sections were costained for α-SMA (purple) actin; EC-SOD, and HA-BP to detect perivascular hyaluronan (brown). Representative images taken at ×40 magnification (scale bars = 50 μm) from n = 3–5 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice used were male. α-SMA, α-smooth muscle actin; EC-SOD, extracellular superoxide dismutase; HA, hyaluronan; HA-BP, hyaluronan-binding protein; Hx, hypoxia; IMs, interstitial macrophages; KO, knockout; Lyve1, lymphatic vessel endothelial hyaluronan receptor 1; Nx, normoxia; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain; WT, wild type.

    Techniques Used: Staining, Immunofluorescence, Imaging, Software, Binding Assay, Knock-Out



    Similar Products

    94
    R&D Systems antibodies against ec sod
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Antibodies Against Ec Sod, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc12442531-87-45-50?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    antibodies against ec sod - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    95
    R&D Systems primary antibodies against ec sod
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Primary Antibodies Against Ec Sod, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pm40332405-105-20-26?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    primary antibodies against ec sod - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    90
    Agilent technologies antibody against ec-sod or ceruloplasmin
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Antibody Against Ec Sod Or Ceruloplasmin, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc04609374-105-23-24?v=Agilent+technologies
    Average 90 stars, based on 1 article reviews
    antibody against ec-sod or ceruloplasmin - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology antibodies against ec sod
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Antibodies Against Ec Sod, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc09827811-125-12-18?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    antibodies against ec sod - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology antibodies against ec-sod
    Low vascular <t>EC-SOD</t> exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.
    Antibodies Against Ec Sod, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc09827811-129-4-14?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    antibodies against ec-sod - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    91
    Novus Biologicals antibody against human sod3
    Figure 5 Vascular endothelial growth factor C regulates <t>Sod3</t> expression in 66 cl4 mammary carcinoma cells. (A) Total RNA from 66 cl4-scramble and 66 cl4-VEGF-C KD2 cells was converted to cDNA and used to perform a mouse oxidative stress PCR array. Nine candidate genes of the eighty-four examined were identified in the PCR array with more than a twofold change in response to VEGF-C KD. (B) Sod3 mRNA expression was determined using a real-time PCR SYBR Green assay on 66 cl4-scram and 66 cl4-VEGF-C KD1 and KD2 cells (top). Western blot analysis of Sod3 expression in 66 cl4-scram and VEGF-C KD1 and KD2 cells (bottom). (C) Sod3 mRNA expression was determined by real-time PCR SYBR Green assay on three pairs of 66 cl4-scram and VEGF-C KD1 or KD2 tumors (each pair was derived from the same animal).
    Antibody Against Human Sod3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pm25358638-106-0-7?v=Novus+Biologicals
    Average 91 stars, based on 1 article reviews
    antibody against human sod3 - by Bioz Stars, 2026-08
    91/100 stars
      Buy from Supplier

    90
    Stressgen Biotechnologies antibodies against cu/zn-sod, mn-sod, ec-sod
    Figure 5 Vascular endothelial growth factor C regulates <t>Sod3</t> expression in 66 cl4 mammary carcinoma cells. (A) Total RNA from 66 cl4-scramble and 66 cl4-VEGF-C KD2 cells was converted to cDNA and used to perform a mouse oxidative stress PCR array. Nine candidate genes of the eighty-four examined were identified in the PCR array with more than a twofold change in response to VEGF-C KD. (B) Sod3 mRNA expression was determined using a real-time PCR SYBR Green assay on 66 cl4-scram and 66 cl4-VEGF-C KD1 and KD2 cells (top). Western blot analysis of Sod3 expression in 66 cl4-scram and VEGF-C KD1 and KD2 cells (bottom). (C) Sod3 mRNA expression was determined by real-time PCR SYBR Green assay on three pairs of 66 cl4-scram and VEGF-C KD1 or KD2 tumors (each pair was derived from the same animal).
    Antibodies Against Cu/Zn Sod, Mn Sod, Ec Sod, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pm25451690-80-27-30?v=Stressgen+Biotechnologies
    Average 90 stars, based on 1 article reviews
    antibodies against cu/zn-sod, mn-sod, ec-sod - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Assay Designs Inc primary antibodies against ec-sod
    Figure 5 Vascular endothelial growth factor C regulates <t>Sod3</t> expression in 66 cl4 mammary carcinoma cells. (A) Total RNA from 66 cl4-scramble and 66 cl4-VEGF-C KD2 cells was converted to cDNA and used to perform a mouse oxidative stress PCR array. Nine candidate genes of the eighty-four examined were identified in the PCR array with more than a twofold change in response to VEGF-C KD. (B) Sod3 mRNA expression was determined using a real-time PCR SYBR Green assay on 66 cl4-scram and 66 cl4-VEGF-C KD1 and KD2 cells (top). Western blot analysis of Sod3 expression in 66 cl4-scram and VEGF-C KD1 and KD2 cells (bottom). (C) Sod3 mRNA expression was determined by real-time PCR SYBR Green assay on three pairs of 66 cl4-scram and VEGF-C KD1 or KD2 tumors (each pair was derived from the same animal).
    Primary Antibodies Against Ec Sod, supplied by Assay Designs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pm22251572-92-7-10?v=Assay+Designs+Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against ec-sod - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Stressgen Biotechnologies antibodies against mn-sod, cu/zn-sod and ec-sod
    Apoptotic stimuli seem activate NF-κB pathway which regulate reactive oxygen species (ROS) production. Whereas in pancreatic CF cells ROS are derived from mitochondria (red lines), in tracheal CF cells ROS are produced mainly by NADPH oxidase (blue lines). In addition, in both types of CF cells, a reduced anti-oxidant defense mechanism at least in part via diminished <t>EC-SOD</t> activity and reduced Cu/Zn-SOD and Mn-SOD expressions lead to exacerbate oxidative stress.
    Antibodies Against Mn Sod, Cu/Zn Sod And Ec Sod, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+against+ec+sod/pmc03171475-65-9-10?v=Stressgen+Biotechnologies
    Average 90 stars, based on 1 article reviews
    antibodies against mn-sod, cu/zn-sod and ec-sod - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Low vascular EC-SOD exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.

    Journal: American journal of physiology. Lung cellular and molecular physiology

    Article Title: Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia

    doi: 10.1152/ajplung.00399.2024

    Figure Lengend Snippet: Low vascular EC-SOD exacerbates hypoxia-induced interstitial macrophage accumulation. Flow cytometric analysis of lung interstitial macrophage (IM) numbers in mice expressing low vascular EC-SOD (EC-SOD SMC KO; EC-SOD loxp/loxp × Tg cre/SMMHC ) compared with floxed wild-type controls (WT; EC-SOD loxp/loxp ) at baseline (normoxia, Nx) and following 4 or 14 days of hypoxia exposure (Hx). Intravenous (IV) CD45 antibody administration was used to exclude intravascular cells as part of the “Dump” gate (gating shown in ). Total macrophages were determined as live IV-CD3 − B220 − Ly6G − CD45 + CD64 + singlets. IMs (CD64 + , CD11b hi CD11c low/int ) and resident alveolar macrophages (AM; CD64 + , CD11b hi CD11c low/int ) were separated based on CD11b and CD11c expression and IM1 (CD11c low MHCII low ), IM2 (CD11c low MHCII hi ), and IM3 (CD11c int MHCII hi ) subsets identified by the expression of CD11c and MHCII. Total macrophages ( A ), interaction (hypoxia:genotype) P = 0.01480; resident AMs ( B ), interaction (hypoxia:genotype) P = 0.02250; total IMs ( C ), interaction (hypoxia:genotype) P = 0.04467; IM1( D ), interaction (hypoxia:genotype) P = 0.02789; IM2 ( E ), interaction (hypoxia: genotype) P = 0.06856; and IM3 ( F ) counts, interaction (hypoxia:genotype) P = 0.04813 in whole lung over the hypoxia time course. Two-factor aligned rank test ANOVA, Tukey’s post hoc tests for comparisons, all P values where P < 0.2 are shown. n = 10–15 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice are male. All data are nonparametric and expressed as median ± interquartile range. EC-SOD, extracellular superoxide dismutase; KO, knockout; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain.

    Article Snippet: Membranes were activated in methanol and blocked with 5% nonfat dry milk powder in Tris-buffered saline with 0.1% Tween 20 (TBST) for at least 1 h. After blocking, membranes were cut below the 75 kDa molecular weight marker and incubated overnight at 4°C with primary antibodies against EC-SOD (goat anti-mouse, R&D Systems, 1:800) or vinculin (rabbit anti-mouse, Cell Signaling Technology, 1:1,000) in 5% milkTBST.

    Techniques: Expressing, Knock-Out

    Single dose of SOD mimetic before hypoxia attenuates pulmonary hypertension and vascular remodeling. A : chronic hypoxic pulmonary hypertension was assessed by direct right ventricle (RV) puncture and measurement of RV systolic pressure (RVSP). B : RV hypertrophy was assessed by right ventricle/left ventricle + septum weights. Muscularization of small pulmonary vessels after 21 days of hypoxia was evaluated using α-smooth muscle actin (α-SMA) antibody staining (purple) of lung sections from hypoxic mice treated with SOD mimetic or vehicle (PBS) compared with normoxic controls. Costaining was performed with HA-BP to also detect hyaluronan (brown). C : vessel muscularization at 21 days was quantified by counting the number of muscularized small vessels (<50 μm) with positive staining for α-SMA counted per high-power field (HPF). D : representative images taken at ×10 magnification (scale bars represent 200 μm) with muscularized vessels indicated with black arrows. One-way ANOVA, Tukey’s post hoc tests for multiple comparisons, n = 5–9 mice per group. Female mice indicated with closed symbols. All data expressed as means ± SD. HA-BP, hyaluronan-binding protein; Hx, hypoxia; Nx, normoxia; SOD, superoxide dismutase.

    Journal: American journal of physiology. Lung cellular and molecular physiology

    Article Title: Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia

    doi: 10.1152/ajplung.00399.2024

    Figure Lengend Snippet: Single dose of SOD mimetic before hypoxia attenuates pulmonary hypertension and vascular remodeling. A : chronic hypoxic pulmonary hypertension was assessed by direct right ventricle (RV) puncture and measurement of RV systolic pressure (RVSP). B : RV hypertrophy was assessed by right ventricle/left ventricle + septum weights. Muscularization of small pulmonary vessels after 21 days of hypoxia was evaluated using α-smooth muscle actin (α-SMA) antibody staining (purple) of lung sections from hypoxic mice treated with SOD mimetic or vehicle (PBS) compared with normoxic controls. Costaining was performed with HA-BP to also detect hyaluronan (brown). C : vessel muscularization at 21 days was quantified by counting the number of muscularized small vessels (<50 μm) with positive staining for α-SMA counted per high-power field (HPF). D : representative images taken at ×10 magnification (scale bars represent 200 μm) with muscularized vessels indicated with black arrows. One-way ANOVA, Tukey’s post hoc tests for multiple comparisons, n = 5–9 mice per group. Female mice indicated with closed symbols. All data expressed as means ± SD. HA-BP, hyaluronan-binding protein; Hx, hypoxia; Nx, normoxia; SOD, superoxide dismutase.

    Article Snippet: Membranes were activated in methanol and blocked with 5% nonfat dry milk powder in Tris-buffered saline with 0.1% Tween 20 (TBST) for at least 1 h. After blocking, membranes were cut below the 75 kDa molecular weight marker and incubated overnight at 4°C with primary antibodies against EC-SOD (goat anti-mouse, R&D Systems, 1:800) or vinculin (rabbit anti-mouse, Cell Signaling Technology, 1:1,000) in 5% milkTBST.

    Techniques: Staining, Binding Assay

    Perivascular Lyve1 + IMs are increased in EC-SOD SMC KO following 4 days of hypoxia and colocalize with HA. Lung sections were stained with a panel of antibodies to identify macrophage populations around pulmonary vessels in floxed WT controls and EC-SOD SMC KO mice at baseline (left hand side images) and during peak hypoxia-induced IM accumulation (4 D Hx; right hand side images). Immunofluorescence imaging was performed on the Vectra Polaris (Akoya) using inForm software. F480 was used to label all macrophages in white ( A ), CD163 in green ( B ), and Lyve1 in yellow ( C ) were used to label the Lyve1 + IM subset. α-SMA was used to identify smooth muscle (blue) in panels. Representative images showing increased interstitial macrophages in hypoxic WT and hypoxic EC-SOD SMC KO mice are shown from n = 3 mice per group; 40 magnification, scale bars 20 μm. White arrows indicate Lyve1-IMs and yellow arrows indicate Lyve1 + IMs in each section. D : adjacent lung sections were costained for α-SMA (purple) actin; EC-SOD, and HA-BP to detect perivascular hyaluronan (brown). Representative images taken at ×40 magnification (scale bars = 50 μm) from n = 3–5 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice used were male. α-SMA, α-smooth muscle actin; EC-SOD, extracellular superoxide dismutase; HA, hyaluronan; HA-BP, hyaluronan-binding protein; Hx, hypoxia; IMs, interstitial macrophages; KO, knockout; Lyve1, lymphatic vessel endothelial hyaluronan receptor 1; Nx, normoxia; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain; WT, wild type.

    Journal: American journal of physiology. Lung cellular and molecular physiology

    Article Title: Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia

    doi: 10.1152/ajplung.00399.2024

    Figure Lengend Snippet: Perivascular Lyve1 + IMs are increased in EC-SOD SMC KO following 4 days of hypoxia and colocalize with HA. Lung sections were stained with a panel of antibodies to identify macrophage populations around pulmonary vessels in floxed WT controls and EC-SOD SMC KO mice at baseline (left hand side images) and during peak hypoxia-induced IM accumulation (4 D Hx; right hand side images). Immunofluorescence imaging was performed on the Vectra Polaris (Akoya) using inForm software. F480 was used to label all macrophages in white ( A ), CD163 in green ( B ), and Lyve1 in yellow ( C ) were used to label the Lyve1 + IM subset. α-SMA was used to identify smooth muscle (blue) in panels. Representative images showing increased interstitial macrophages in hypoxic WT and hypoxic EC-SOD SMC KO mice are shown from n = 3 mice per group; 40 magnification, scale bars 20 μm. White arrows indicate Lyve1-IMs and yellow arrows indicate Lyve1 + IMs in each section. D : adjacent lung sections were costained for α-SMA (purple) actin; EC-SOD, and HA-BP to detect perivascular hyaluronan (brown). Representative images taken at ×40 magnification (scale bars = 50 μm) from n = 3–5 mice per group. Due to the SMMHC promotor’s location on the Y chromosome, all mice used were male. α-SMA, α-smooth muscle actin; EC-SOD, extracellular superoxide dismutase; HA, hyaluronan; HA-BP, hyaluronan-binding protein; Hx, hypoxia; IMs, interstitial macrophages; KO, knockout; Lyve1, lymphatic vessel endothelial hyaluronan receptor 1; Nx, normoxia; SMC, smooth muscle cell; SMMHC, SMC myosin heavy chain; WT, wild type.

    Article Snippet: Membranes were activated in methanol and blocked with 5% nonfat dry milk powder in Tris-buffered saline with 0.1% Tween 20 (TBST) for at least 1 h. After blocking, membranes were cut below the 75 kDa molecular weight marker and incubated overnight at 4°C with primary antibodies against EC-SOD (goat anti-mouse, R&D Systems, 1:800) or vinculin (rabbit anti-mouse, Cell Signaling Technology, 1:1,000) in 5% milkTBST.

    Techniques: Staining, Immunofluorescence, Imaging, Software, Binding Assay, Knock-Out

    Figure 5 Vascular endothelial growth factor C regulates Sod3 expression in 66 cl4 mammary carcinoma cells. (A) Total RNA from 66 cl4-scramble and 66 cl4-VEGF-C KD2 cells was converted to cDNA and used to perform a mouse oxidative stress PCR array. Nine candidate genes of the eighty-four examined were identified in the PCR array with more than a twofold change in response to VEGF-C KD. (B) Sod3 mRNA expression was determined using a real-time PCR SYBR Green assay on 66 cl4-scram and 66 cl4-VEGF-C KD1 and KD2 cells (top). Western blot analysis of Sod3 expression in 66 cl4-scram and VEGF-C KD1 and KD2 cells (bottom). (C) Sod3 mRNA expression was determined by real-time PCR SYBR Green assay on three pairs of 66 cl4-scram and VEGF-C KD1 or KD2 tumors (each pair was derived from the same animal).

    Journal: Breast cancer research : BCR

    Article Title: Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.

    doi: 10.1186/s13058-014-0462-2

    Figure Lengend Snippet: Figure 5 Vascular endothelial growth factor C regulates Sod3 expression in 66 cl4 mammary carcinoma cells. (A) Total RNA from 66 cl4-scramble and 66 cl4-VEGF-C KD2 cells was converted to cDNA and used to perform a mouse oxidative stress PCR array. Nine candidate genes of the eighty-four examined were identified in the PCR array with more than a twofold change in response to VEGF-C KD. (B) Sod3 mRNA expression was determined using a real-time PCR SYBR Green assay on 66 cl4-scram and 66 cl4-VEGF-C KD1 and KD2 cells (top). Western blot analysis of Sod3 expression in 66 cl4-scram and VEGF-C KD1 and KD2 cells (bottom). (C) Sod3 mRNA expression was determined by real-time PCR SYBR Green assay on three pairs of 66 cl4-scram and VEGF-C KD1 or KD2 tumors (each pair was derived from the same animal).

    Article Snippet: Antibody against human SOD3 was obtained from Novus Biologicals (NBP1-22417; Littleton, CO, USA).

    Techniques: Expressing, Real-time Polymerase Chain Reaction, SYBR Green Assay, Western Blot, Derivative Assay

    Figure 8 Expression of VEGFC and SOD3 in human cancers. (A) VEGFC and SOD3 expression values were retrieved from an Oncomine microarray data set [43] (as indicated in the figure) and were plotted by expression value. Statistical analysis was performed using Pearson r correlation (two-tailed). (B) Proposed model for the function of vascular endothelial growth factor C (VEGF-C) in breast cancer progression. Expression of VEGF-C in a subset of tumor cells confers the ability to resist oxidative stress generated during tumor growth, and this ability is partially mediated by Sod3. However, VEGF-C mediates other pathways that are important in conferring resistance to chemotherapies, thus contributing to tumor recurrence. Blocking VEGF-C signaling would therefore be expected to sensitize breast cancers to chemotherapies that induce oxidative stress, to contribute to a reduction in tumor-initiating cells (TICs) and to decrease lymphangiogenesis, thus likely improving survival and prevent recurrence.

    Journal: Breast cancer research : BCR

    Article Title: Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.

    doi: 10.1186/s13058-014-0462-2

    Figure Lengend Snippet: Figure 8 Expression of VEGFC and SOD3 in human cancers. (A) VEGFC and SOD3 expression values were retrieved from an Oncomine microarray data set [43] (as indicated in the figure) and were plotted by expression value. Statistical analysis was performed using Pearson r correlation (two-tailed). (B) Proposed model for the function of vascular endothelial growth factor C (VEGF-C) in breast cancer progression. Expression of VEGF-C in a subset of tumor cells confers the ability to resist oxidative stress generated during tumor growth, and this ability is partially mediated by Sod3. However, VEGF-C mediates other pathways that are important in conferring resistance to chemotherapies, thus contributing to tumor recurrence. Blocking VEGF-C signaling would therefore be expected to sensitize breast cancers to chemotherapies that induce oxidative stress, to contribute to a reduction in tumor-initiating cells (TICs) and to decrease lymphangiogenesis, thus likely improving survival and prevent recurrence.

    Article Snippet: Antibody against human SOD3 was obtained from Novus Biologicals (NBP1-22417; Littleton, CO, USA).

    Techniques: Expressing, Microarray, Two Tailed Test, Generated, Blocking Assay

    Apoptotic stimuli seem activate NF-κB pathway which regulate reactive oxygen species (ROS) production. Whereas in pancreatic CF cells ROS are derived from mitochondria (red lines), in tracheal CF cells ROS are produced mainly by NADPH oxidase (blue lines). In addition, in both types of CF cells, a reduced anti-oxidant defense mechanism at least in part via diminished EC-SOD activity and reduced Cu/Zn-SOD and Mn-SOD expressions lead to exacerbate oxidative stress.

    Journal: PLoS ONE

    Article Title: Increased Oxidative Stress Induces Apoptosis in Human Cystic Fibrosis Cells

    doi: 10.1371/journal.pone.0024880

    Figure Lengend Snippet: Apoptotic stimuli seem activate NF-κB pathway which regulate reactive oxygen species (ROS) production. Whereas in pancreatic CF cells ROS are derived from mitochondria (red lines), in tracheal CF cells ROS are produced mainly by NADPH oxidase (blue lines). In addition, in both types of CF cells, a reduced anti-oxidant defense mechanism at least in part via diminished EC-SOD activity and reduced Cu/Zn-SOD and Mn-SOD expressions lead to exacerbate oxidative stress.

    Article Snippet: Blots were probed with antibodies against Mn-SOD, Cu/Zn-SOD and EC-SOD (Stressgen, MI), and developed with horseradish peroxidase-conjugated secondary antibody.

    Techniques: Derivative Assay, Produced, Activity Assay